Laxmi Organic Industries Ltd

Laxmi Organic Industries announced that the 36th Annual General Meeting(AGM) of the company will be held on 31 July 2025.Powered by Capital Market - Live

Laxmi Organic Industries announced that the Board of Directors of the Company at its meeting held on 20 May 2025, inter alia, have recommended the final dividend of Rs 0.5 per equity Share (i.e. 25%) , subject to the approval of the shareholders.Powered by Capital Market - Live

Revenue from operations stood at Rs 709.69 crore in Q4 FY25, registering a de-growth of 10.39% from Rs 792.06 crore recorded in the corresponding quarter of the previous year. Profit before tax slumped 80.52% year on year to Rs 13.24 crore in the quarter ended 31 March 2025. EBITDA tumbled 34% to Rs 590 crore in Q4 FY25 from Rs 900 crore reported in Q4 FY24. The EBITDA margin declined to 8.3% in Q4 FY25, compared to 11.5% in the corresponding quarter of the previous year. On a full-year basis, the company's consolidated net profit declined 5.84% to Rs 113.50 crore on a 4.20% increase in revenue from operations to Rs 2,985.44 crore in FY25 over FY24. Rajan Venkatesh, MD and CEO of Laxmi Organic Industries, said, 'We have achieved 11% volume growth and a 9.4% EBITDA growth YoY, while maintaining our profitability despite the prevailing environment and the evolving geopolitical backdrop and its consequences. This growth was driven by our focus on a) operational efficiency efforts resulting in both increased volumes and improved cost competitiveness, b) capacity augmentation, c) our customer-centric approach, which has enabled us to expand our market share and reach new customers and industries, and d) prudent cost and fund management. Innovation keeps businesses relevant, dynamic, and poised for long-term success. On that note, we inaugurated Laxmi's New Innovation Center at Mahape, Navi Mumbai, in Q4FY25. It is tailored to meet the needs of our dynamic workforce and support our customers' ambitions. Our Fluoro-intermediates site has commenced generating revenues from Q4FY25, expanding our overall specialties intermediate product offerings to our customers. I am excited to share that Laxmi and Hitachi Energy have signed a Letter of Intent to set up production of an eco-efficient gas used in Hitachi Energy's SF6-free high-voltage switchgear portfolio. Commercial production can begin in the next financial year, thus contributing to a sustainable future in power transmission and distribution. This emphasizes Laxmi's focus on supporting our customers' ambitions by leveraging its technology platforms, in this case fluorination. At our upcoming Dahej site, we received Environmental Clearance and Factory License approvals in Q1FY26, and the project remains on schedule in terms of timelines, scope, and cost. As Team Laxmi, we remain #GearedtoWin and #GearedforGrowth as we work diligently towards our plans for FY28. I would like to express my deep appreciation to the entire Laxmi Organic team, our customers, the board of directors, our investors, the communities where we operate our sites, and other related stakeholders.' Meanwhile, the company's board has recommended a final dividend of Rs 0.50 per share, subject to approval at the 36th Annual General Meeting. The Board of Directors has fixed Friday, 18 July 2025, as the record date to determine eligibility for the dividend for the financial year 2024-25, if declared at the AGM scheduled for 31 July 2025. Laxmi Organic Industries is a leading manufacturer of acetyl intermediates and specialty intermediates with almost three decades of experience in large-scale manufacturing of chemicals. Powered by Capital Market - Live

Net profit of Laxmi Organic Industries declined 50.89% to Rs 21.76 crore in the quarter ended March 2025 as against Rs 44.31 crore during the previous quarter ended March 2024. Sales declined 10.40% to Rs 709.69 crore in the quarter ended March 2025 as against Rs 792.06 crore during the previous quarter ended March 2024. For the full year,net profit declined 5.84% to Rs 113.50 crore in the year ended March 2025 as against Rs 120.54 crore during the previous year ended March 2024. Sales rose 4.20% to Rs 2985.44 crore in the year ended March 2025 as against Rs 2865.01 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales709.69792.06 -10 2985.442865.01 4 OPM %8.3111.36 -9.378.93 - PBDT52.7598.54 -46 284.55277.39 3 PBT13.2467.99 -81 160.52170.80 -6 NP21.7644.31 -51 113.50120.54 -6 Powered by Capital Market - Live

Laxmi Organic Industries will hold a meeting of the Board of Directors of the Company on 20 May 2025.Powered by Capital Market - Live

Laxmi Organic Industries announced that the company's Site 1 producing chemical products under Essentials Business Unit located at Mahad Industrial Area, MIDC, Raigad ' 402 309, Maharashtra, India, will be undergoing a Scheduled Annual Boiler Shutdown from May 14, 2025 until 28 May 2025. The Company's supply chain and sales teams have taken appropriate measures to ensure continuity of deliveries to the extent possible. However, during the shutdown period, product availability may be limited.Powered by Capital Market - Live

Laxmi Organic Industries has received Environmental Clearance (EC) from the State Environment Impact Assessment Authority (SEIAA), Gujarat constituted under the Ministry of Environment, Forest and Climate Change, for its upcoming Synthetic Organic Chemicals Manufacturing site at Dahej, Village Jolve and Vadadala, District Bharuch, Gujarat. Powered by Capital Market - Live

Laxmi Organic Industries has allotted 42,692 equity shares under ESOP. After allotment of aforesaid equity shares, the share capital of the Company stands increased from 55,40,47,626 to 55,41,33,010. Powered by Capital Market - Live

The headline equity benchmarks pared all early losses and traded with modest gains in morning trade. The Nifty traded above the 23,200 level. IT shares extended gains for the second consecutive trading session. Trading could be volatile due to weekly F&O series expiry today. At 10:30 IST, the barometer index, the S&P BSE Sensex rose 235.91 points or 0.31% to 76,640.90. The Nifty 50 index added 82 points or 0.35% to 23,237.35. The broader market outperformed the frontline indices. The S&P BSE Mid-Cap index jumped 1.96% and the S&P BSE Small-Cap index rallied 1.24%. The market breadth was strong. On the BSE, 2,411 shares rose and 1,094 shares fell. A total of 174 shares were unchanged. Politics: The JD(U) on Wednesday sacked its Manipur unit president, Ksh. Biren Singh, in an effort to quell growing speculation about its ties with the BJP. Party's national spokesperson Rajiv Ranjan told the media Singh's removal was due to indiscipline and asserted that the party would continue to support the BJP-led government in the northeastern state. Ranjan affirmed that the JD(U) remains committed to supporting the BJP-led NDA, not just in Manipur but across the country. Ranjan's remark came shorty after Ksh Biren Singh claimed that the party had withdrawn support to the BJP-led Biren Singh government and informed its decision to governor Ajay Kumar Bhalla. The state unit chief had also claimed that the lone JDU MLA in the state, Md Abdul Nasir, will sit in the opposition benches. Result Today: UltraTech Cement (up 1.70%), Dr Reddy's Laboratories (down 0.77%), Hindustan Petroleum Corporation (down 1.18%), Indus Towers (up 2.06%), United Spirits (up 2.03%), Adani Energy Solutions (up 0.23%), Adani Green Energy (up 1.32%), Amber Enterprises India (up 10.35%), Capri Global Capital (up 1.34%), Cyient (up 1.74%), Greaves Cotton (up 2.88%), Indian Energy Exchange (down 0.15%), KFin Technologies (up 4.99%), Mankind Pharma (up 1.33%), Mphasis (up 3.44%), Nippon Life India Asset Management (up 2.64%), Senores Pharmaceuticals (up 2.52%), Sona BLW Precision Forgings (up 2.05%), Spandana Sphoorty Financial (down 0.08%), Suryoday Small Finance Bank (up 1.82%), Syngene International (down 0.19%), Tejas Networks (up 1.40%), Thyrocare Technologies (up 1.87%), Ujjivan Small Finance Bank (up 0.84%), V2 Retail (up 3.26%) and Zee Entertainment Enterprises (up 1.44%) will announce their quarterly later today. New Listing: Shares of Stallion India Fluorochemicals was locked in upper circuit of 5% at Rs 125.99 at 10:22 IST on the BSE, representing a premium of 39.99% as compared with the issue price of Rs 90. The scrip was listed at Rs 120, exhibiting a premium of 33.33% to the issue price. So far, the stock has hit a high of 125.99 and a low of 120. On the BSE, over 7.27 lakh shares of the company were traded in the counter so far Buzzing Index: The Nifty IT index jumped 2.18% to 43,517.05. The index rallied 4.36% in two consecutive trading sessions. Coforge (up 10.78%), Persistent Systems (up 9.41%), Wipro (up 4.59%), Mphasis (up 3.31%), LTIMindtree (up 2.76%), Tech Mahindra (up 1.81%), L&T Technology Services (up 1.68%), Infosys (up 0.62%) and Tata Consultancy Services (up 0.51%) advanced. Stocks in Spotlight: Laxmi Organic Industries rallied 4.20% after the company's consolidated net profit jumped 7.76% to Rs 29.30 crore in Q3 FY25 as against Rs 27.18 crore reported in Q3 FY24. Revenue from operations stood at Rs 786.34 crore in Q3 FY25, marking a growth of 13.25% from Rs 694.30 crore recorded in the corresponding quarter last year. Persistent Systems surged 9.83% after the company's consolidated net profit jumped 14.77% to Rs 372.99 crore in Q3 FY25 as compared with Rs 325 crore in Q2 FY25. Revenue from operations increased 5.7% QoQ to Rs 3,062.28 crore in Q3 FY25. Piramal Pharma advanced 2.02% after the company said that its subsidiary Piramal Critical Care (PCC) has launched Chlorpromazine Hydrochloride for Injection in various strengths in the US market. Powered by Capital Market - Live

Revenue from operations stood at Rs 786.34 crore in Q3 FY25, marking a growth of 13.25% from Rs 694.30 crore recorded in the corresponding quarter last year. Profit before tax surged 59.22% year on year to Rs 47.05 crore in the quarter ended 31 December 2024. EBITDA jumped 43.02% to Rs 74.80 crore in Q3 FY25 from Rs 52.30 crore posted in Q3 FY24. EBITDA margin advanced to 9.5% in Q3 FY25 as compared with 7.55% reported in the corresponding quarter previous year. On a nine-month basis, the company's net profit rose 20.34% to Rs 91.74 crore on 9.63% increase in revenue to Rs 2,275.8 crore in 9M FY25 over 9M FY24. Dr. Rajan Venkatesh, MD and CEO, Laxmi Organic Industries, said, 'We have continued our growth journey and delivered double-digit growth in volumes, revenue, and EBITDA in Q3 b) capacity augmentation; and c) our customer-centric approach, which has enabled us to expand our market share and widen our reach to new customers & industries. At our Fluoro-intermediates site, we are steadily changing gears and are now focused on generating revenues from Q4FY25 to expand our overall Specialties intermediate product offerings to our customers. At our Dahej site, we continue to remain on track to receive the pending regulatory approvals, and the project remains on schedule on timelines and budget. We remain #GearedtoWin and #GearedforGrowth to achieve our laid-out plans for FY28. I would like to share my deep appreciation with the whole Laxmi Organic team, our customers, and all related stakeholders.' Laxmi Organic Industries is a leading manufacturer of acetyl intermediates and specialty intermediates with almost three decades of experience in large-scale manufacturing of chemicals. Powered by Capital Market - Live